| Stereochemistry | RACEMIC |
| Molecular Formula | C20H24N2S2 |
| Molecular Weight | 356.548 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CSC1=CC2=C(SC3=C(CC2N4CCN(C)CC4)C=CC=C3)C=C1
InChI
InChIKey=RLJFTICUTYVZDG-UHFFFAOYSA-N
InChI=1S/C20H24N2S2/c1-21-9-11-22(12-10-21)18-13-15-5-3-4-6-19(15)24-20-8-7-16(23-2)14-17(18)20/h3-8,14,18H,9-13H2,1-2H3
| Molecular Formula | C20H24N2S2 |
| Molecular Weight | 356.548 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 56.0 nM [IC50] | |||
| 8.68 null [pKi] | |||
| 8.35 null [pKi] | |||
| 71.0 nM [IC50] | |||
| 4.7 nM [IC50] | |||
| 1.5 nM [IC50] | |||
| 2.0 nM [Ki] | |||
| 0.4 nM [Ki] |
